{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:40:28Z","timestamp":1783647628707,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DFG","award":["EH 192\/5-3"],"award-info":[{"award-number":["EH 192\/5-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>There are over 100 known human adenovirus (HAdV) types, which are able to cause a broad variety of different self-limiting but also lethal diseases especially in immunocompromised patients. Only limited information about the pathogenesis and biology of the majority of these virus types is available. In the present study, we performed a systematic screen for coxsackievirus and adenovirus receptor (CAR)-usage of a large spectrum of HAdV types.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>To study receptor usage we utilized a recombinant HAdV library containing HAdV genomes tagged with a luciferase and GFP encoding transgene. We infected CHO-CAR cells stably expressing the CAR receptor and control cells lacking the CAR receptor with tagged viruses (HAdV3, 14, 16, 50, 10, 24, 27, 37 and 69) and measured luciferase expression levels 26 and for some viruses (AdV10, \u2212\u200924 and \u2212\u200927) 52\u2009h post-infection. As positive control, we applied human adenovirus type 5 (HAdV5) known to use the CAR receptor for cell entry. For viruses replication studies on genome level we applied digital PCR.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Infection of CHO-CAR and CHO-K1 cells at various virus particle numbers per cell (vpc) revealed that HAdV10, 24, and 27 showed similar or decreased luciferase expression levels in the presence of CAR. In contrast, HAdV3, 14, 16, 50, 37 and 69 resulted in increased luciferase expression levels in our initial screening experiments. CAR usage of HAdV3, 14, 50, and 69 was not studied before, and therefore we experimentally confirmed CAR usage for these HAdV as novel viruses utilizing CAR as a receptor. To rule out that replication of HAdV in transduced CHO cells is responsible for increased transduction rates we performed replication assays on virus genome level, which revealed that there is no HAdV replication.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In the present study, we screened a HAdV library and identified novel human HAdV using the CAR receptor. To our knowledge, this is the first description of CAR usage for HAdV 3, 14, 50, and 69.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12985-020-01318-w","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T15:03:47Z","timestamp":1586444627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry"],"prefix":"10.1186","volume":"17","author":[{"given":"Kemal","family":"Mese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Bunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schellhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Volkwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Baiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"1318_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","volume":"4","author":"B Ghebremedhin","year":"2014","unstructured":"Ghebremedhin B. Human adenovirus: viral pathogen with increasing importance. Eur J Microbiol Immunol (Bp). 2014;4:26\u201333.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cmi.12031","volume":"15","author":"UF Greber","year":"2013","unstructured":"Greber UF, Arnberg N, Wadell G, Benko M, Kremer EJ. Adenoviruses - from pathogens to therapeutics: a report on the 10th international adenovirus meeting. Cell Microbiol. 2013;15:16\u201323.","journal-title":"Cell Microbiol"},{"key":"1318_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1126\/science.1187292","volume":"329","author":"VS Reddy","year":"2010","unstructured":"Reddy VS, Natchiar SK, Stewart PL, Nemerow GR. Crystal structure of human adenovirus at 3.5 a resolution. Science. 2010;329:1071\u20135.","journal-title":"Science"},{"key":"1318_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/nm952","volume":"9","author":"A Gaggar","year":"2003","unstructured":"Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med. 2003;9:1408\u201312.","journal-title":"Nat Med"},{"key":"1318_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nm.2270","volume":"17","author":"H Wang","year":"2011","unstructured":"Wang H, Li ZY, Liu Y, Persson J, Beyer I, Moller T, Koyuncu D, Drescher MR, Strauss R, Zhang XB, et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med. 2011;17:96\u2013104.","journal-title":"Nat Med"},{"key":"1318_CR6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1128\/JVI.06181-11","volume":"86","author":"HV Trinh","year":"2012","unstructured":"Trinh HV, Lesage G, Chennamparampil V, Vollenweider B, Burckhardt CJ, Schauer S, Havenga M, Greber UF, Hemmi S. Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J Virol. 2012;86:1623\u201337.","journal-title":"J Virol"},{"key":"1318_CR7","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1128\/JVI.75.18.8772-8780.2001","volume":"75","author":"MC Dechecchi","year":"2001","unstructured":"Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, Cabrini G. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol. 2001;75:8772\u201380.","journal-title":"J Virol"},{"key":"1318_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","volume":"74","author":"N Arnberg","year":"2000","unstructured":"Arnberg N, Edlund K, Kidd AH, Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol. 2000;74:42\u20138.","journal-title":"J Virol"},{"key":"1318_CR9","doi-asserted-by":"publisher","first-page":"e1004657","DOI":"10.1371\/journal.ppat.1004657","volume":"11","author":"A Lenman","year":"2015","unstructured":"Lenman A, Liaci AM, Liu Y, \u00c5rdahl C, Rajan A, Nilsson E, Bradford W, Kaeshammer L, Jones MS, Fr\u00e4ngsmyr L. Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cells. PLoS Pathog. 2015;11:e1004657.","journal-title":"PLoS Pathog"},{"key":"1318_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature04721","volume":"441","author":"DM Roberts","year":"2006","unstructured":"Roberts DM, Nanda A, Havenga MJ, Abbink P, Lynch DM, Ewald BA, Liu J, Thorner AR, Swanson PE, Gorgone DA, et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature. 2006;441:239\u201343.","journal-title":"Nature"},{"key":"1318_CR11","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320\u20133.","journal-title":"Science"},{"key":"1318_CR12","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","volume":"79","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Bergelson JM. Adenovirus Receptors. J Virol. 2005;79:12125\u201331.","journal-title":"J Virol"},{"key":"1318_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","volume":"33","author":"N Arnberg","year":"2012","unstructured":"Arnberg N. Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol Sci. 2012;33:442\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"1318_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11262-017-1487-2","volume":"53","author":"W Zhang","year":"2017","unstructured":"Zhang W, Ehrhardt A. Getting genetic access to natural adenovirus genomes to explore vector diversity. Virus Genes. 2017;53:675\u201383.","journal-title":"Virus Genes"},{"key":"1318_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.virol.2004.04.001","volume":"324","author":"SM Cashman","year":"2004","unstructured":"Cashman SM, Morris DJ, Kumar-Singh R. Adenovirus type 5 pseudotyped with adenovirus type 37 fiber uses sialic acid as a cellular receptor. Virology. 2004;324:129\u201339.","journal-title":"Virology"},{"key":"1318_CR16","doi-asserted-by":"publisher","first-page":"33704","DOI":"10.1074\/jbc.M605316200","volume":"281","author":"E Seiradake","year":"2006","unstructured":"Seiradake E, Lortat-Jacob H, Billet O, Kremer EJ, Cusack S. Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor. J Biol Chem. 2006;281:33704\u201316.","journal-title":"J Biol Chem"},{"key":"1318_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/jmv.10382","volume":"70","author":"A Heim","year":"2003","unstructured":"Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003;70:228\u201339.","journal-title":"J Med Virol"},{"key":"1318_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.virol.2006.07.048","volume":"357","author":"D Kolodkin-Gal","year":"2007","unstructured":"Kolodkin-Gal D, Zamir G, Pikarski E, Pikarski A, Shimony N, Wu H, Haviv Y, Panet A. A novel system to study adenovirus tropism to normal and malignant colon tissues. Virology. 2007;357:91\u2013101.","journal-title":"Virology"},{"key":"1318_CR19","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3892\/mmr.2016.5536","volume":"14","author":"YY Ma","year":"2016","unstructured":"Ma YY, Wang XJ, Han Y, Li G, Wang HJ, Wang SB, Chen XY, Liu FL, He XL, Tong XM. Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: a potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population. Mol Med Rep. 2016;14:2541\u20137.","journal-title":"Mol Med Rep"},{"key":"1318_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/jmv.23736","volume":"86","author":"D Markel","year":"2014","unstructured":"Markel D, Lam E, Harste G, Darr S, Ramke M, Heim A. Type dependent patterns of human adenovirus persistence in human T-lymphocyte cell lines. J Med Virol. 2014;86:785\u201394.","journal-title":"J Med Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01318-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-020-01318-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01318-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T23:22:48Z","timestamp":1617924168000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-020-01318-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1186\/s12985-020-01318-w","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"24 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}